The allometry of chronic myeloid leukemia

Journal of Theoretical Biology

Volumn 259, Issue 3, 2009, Pages 635-640

  Pacheco, Jorge M ^a   Traulsen, Arne ^b   Dingli, David ^c  

^a UNIVERSITY OF LISBON   (Portugal)

^b MAX PLANCK INSTITUTE FOR EVOLUTIONARY BIOLOGY   (Germany)

^c MAYO CLINIC   (United States)

Author keywords

Allometry; Chronic myeloid leukemia; Hematopoiesis; Modeling

Indexed keywords

ALLOMETRY; DISEASE; MAMMAL; MODELING; RADIATION EXPOSURE;

ALLOMETRY; ARTICLE; CANCER STEM CELL; CELL DIFFERENTIATION; CHRONIC MYELOID LEUKEMIA; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; MATHEMATICAL MODEL; NONHUMAN; PREDICTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ANIMALIA; ELEPHANTIDAE; MAMMALIA; MURINAE; MUS;

EID: 67649970534     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2009.04.003     Document Type: Article

References (37)

1. Banavar J.R., Maritan A., and Rinaldo A. Size and form in efficient transportation networks. Nature 399 (1999) 130-132
2. Brummendorf T.H., Holyoake T.L., Rufer N., Barnett M.J., Schulzer M., Eaves C.J., Eaves A.C., and Lansdorp P.M. Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry. Blood 95 (2000) 1883-1890
3. Buescher E.S., Alling D.W., and Gallin J.I. Use of an X-linked human neutrophil marker to estimate timing of lyonization and size of the dividing stem cell pool. J. Clin. Invest. 76 (1985) 1581-1584
4. Daley G.Q., Van Etten R.A., and Baltimore D. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247 (1990) 824-830
5. Dingli D., and Pacheco J.M. Allometric scaling of the active hematopoietic stem cell pool across mammals. PLoS ONE 1 (2006) e2
6. Dingli D., Traulsen A., and Michor F. (A)Symmetric stem cell replication and cancer. PLoS Comput. Biol. 3 (2007) e53
7. Dingli D., Traulsen A., and Pacheco J.M. Compartmental architecture and dynamics of hematopoiesis. PLoS ONE 2 (2007) e345
8. Dingli D., Pacheco J.M., and Traulsen A. Multiple mutant clones in blood rarely coexist. Phys. Rev. E Stat. Nonlin. Soft Matter Phys. 77 (2008) 021915
9. Dingli D., Traulsen A., and Pacheco J.M. Chronic myeloid leukemia: origin, development, response to therapy, and relapse. Clin. Leuk. 2 (2008) 133-139
10. Dingli D., Traulsen A., and Pacheco J.M. Dynamics of haemopoiesis across mammals. Proc. Biol. Sci. 275 (2008) 2389-2392
11. Fialkow P.J., Jacobson R.J., and Papayannopoulou T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage. Am. J. Med. 63 (1977) 125-130
12. Frith C.H., Ward J.M., and Chandra M. The morphology, immunohistochemistry, and incidence of hematopoietic neoplasms in mice and rats. Toxicol. Pathol. 21 (1993) 206-218
13. Goldman J.M. Chronic myeloid leukemia-still a few questions. Exp. Hematol. 32 (2004) 2-10
14. Gordon M.Y., Marley S.B., Lewis J.L., Davidson R.J., Nguyen D.X., Grand F.H., Amos T.A., and Goldman J.M. Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM. J. Clin. Invest. 102 (1998) 710-715
15. Groffen J., Stephenson J.R., Heisterkamp N., de Klein A., Bartram C.R., and Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 36 (1984) 93-99
16. Holyoake T.L., Jiang X., Drummond M.W., Eaves A.C., and Eaves C.J. Elucidating critical mechanisms of deregulated stem cell turnover in the chronic phase of chronic myeloid leukemia. Leukemia 16 (2002) 549-558
17. Huntly B.J., Shigematsu H., Deguchi K., Lee B.H., Mizuno S., Duclos N., Rowan R., Amaral S., Curley D., Williams I.R., Akashi K., and Gilliland D.G. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 6 (2004) 587-596
18. Ichimaru M., Tomonaga M., Amenomori T., and Matsuo T. Atomic bomb and leukemia. J. Radiat. Res. (Tokyo) 32 Suppl. 2 (1991) 14-19
19. Ichimaru, M., Ishimaru, T., Mikami, M., Yamada, Y., Ohkita, T., 1981. Incidence of leukemia in a fixed cohort of atomic bomb survivors and controls, Hiroshima and Nagasaki October 1950-December 1978. Technical Report RERF TR 13-81. Radiation Effects Research Foundation, Hiroshima.
20. Jaffe E.S., Harris N.L., Stein H., and Vardiman J.W. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues (2001), IARC Press, Lyon
21. Jamieson C.H., Ailles L.E., Dylla S.J., Muijtjens M., Jones C., Zehnder J.L., Gotlib J., Li K., Manz M.G., Keating A., Sawyers C.L., and Weissman I.L. Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. N. Engl. J. Med. 351 (2004) 657-667
22. Leifer C.E., Matus R.E., Patnaik A.K., and MacEwen E.G. Chronic myelogenous leukemia in the dog. J. Am. Vet. Med. Assoc. 183 (1983) 686-689
23. Lemischka I.R., Raulet D.H., and Mulligan R.C. Developmental potential and dynamic behavior of hematopoietic stem cells. Cell 45 (1986) 917-927
24. Lopes J.V., Pacheco J.M., and Dingli D. Acquired hematopoietic stem-cell disorders and mammalian size. Blood 110 (2007) 4120-4122
25. Marciniak-Czochra A., Stiehl T., Ho A.D., Jager W., and Wagner W. Modeling of asymmetric cell division in hematopoietic stem cells-regulation of self-renewal is essential for efficient repopulation. Stem Cells Dev 18 (2009) 377-385
26. Marley S.B., and Gordon M.Y. Chronic myeloid leukaemia: stem cell derived but progenitor cell driven. Clin. Sci. (London) 109 (2005) 13-25
27. Marley S.B., Lewis J.L., and Gordon M.Y. Progenitor cells divide symmetrically to generate new colony-forming cells and clonal heterogeneity. Br. J. Haematol. 121 (2003) 643-648
28. Martin P.J., Najfeld V., Hansen J.A., Penfold G.K., Jacobson R.J., and Fialkow P.J. Involvement of the B-lymphoid system in chronic myelogenous leukaemia. Nature 287 (1980) 49-50
29. Michor F., Nowak M.A., Frank S.A., and Iwasa Y. Stochastic elimination of cancer cells. Proc. Biol. Sci. 270 (2003) 2017-2024
30. Minami Y., Stuart S.A., Ikawa T., Jiang Y., Banno A., Hunton I.C., Young D.J., Naoe T., Murre C., Jamieson C.H., and Wang J.Y. BCR-ABL-transformed GMP as myeloid leukemic stem cells. Proc. Natl. Acad. Sci. USA 105 (2008) 17967-17972
31. Pacheco J.M., Traulsen A., Antal T., and Dingli D. Cyclic neutropenia in mammals. Am. J. Hematol. 83 (2008) 920-921
32. Pollet L., Van Hove W., and Mattheeuws D. Blastic crisis in chronic myelogenous leukaemia in a dog. J. Small Anim. Pract. 19 (1978) 469-475
33. Rowley J.D. Letter: a new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 243 (1973) 290-293
34. Thomsen M.K., Jensen A.L., Skak-Nielsen T., and Kristensen F. Enhanced granulocyte function in a case of chronic granulocytic leukemia in a dog. Vet. Immunol. Immunopathol. 28 (1991) 143-156
35. Udomsakdi C., Eaves C.J., Swolin B., Reid D.S., Barnett M.J., and Eaves A.C. Rapid decline of chronic myeloid leukemic cells in long-term culture due to a defect at the leukemic stem cell level. Proc. Natl. Acad. Sci. USA 89 (1992) 6192-6196
36. West G.B., Woodruff W.H., and Brown J.H. Allometric scaling of metabolic rate from molecules and mitochondria to cells and mammals. Proc. Natl. Acad. Sci. USA 99 Supply 1 (2002) 2473-2478
37. Zhao R.C., Jiang Y., and Verfaillie C.M. A model of human p210(bcr/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR/ABL-containing retroviral vector. Blood 97 (2001) 2406-2412